← Back to Vaccine Database

HSV529

Live attenuated vaccine · VDDBV0409

Target & Classification

HSVHerpes simplex virus
Live attenuated vaccine
Herpes Simplex Virus 2
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT02571166 Phase 1Herpes Simplex Virus 2
NCT01915212 Phase 1Herpes Simplex Virus 2